The Clinical Utility of FLT3 Mutation Testing in Acute Leukemia: A Canadian Consensus.

FMS-like tyrosine kinase 3 (FLT3) mutations are detected in approximately 20–30% of patients with acute myeloid leukemia (AML), with the presence of a FLT3 internal tandem duplication (FLT3-ITD) mutation being associated with an inferior outcome. Assessment of FLT3 mutational status is now essential...

Descripción completa

Detalles Bibliográficos

Publicado en:	Current Oncology Vol. 30; no. 12; pp. 10410 - 10437
Autores principales:	Bergeron, Julie, Capo-Chichi, Jose-Mario, Tsui, Hubert, Mahe, Etienne, Berardi, Philip, Minden, Mark D., Brandwein, Joseph M., Schuh, Andre C.
Formato:	Journal Article
Publicado:	MDPI Dec2023
Acceso en línea:	Ver este registro en EBSCOhost